Over the years, Prof. Chite has spearheaded various programs that have made groundbreaking transformations in the cancer realm, focusing in all stages from screening, diagnostics, treatment, follow-up care as well as survivorship. He has led the course in championing for improved and advanced cancer care for patients. His major programs, with support from grant awards from strategic partners include the Ampath Breast & Cervical Cancer Control Program (ABCCCP), and Multinational Lung Cancer Control Program (MLCCP) which covers four countries including Kenya, South Africa, Tanzania, & Swaziland (Kingdom of Eswatini), with him as the Chief Principal Investigator. Also, up his sleeves is the Preceptorship Program, Telemedicine Program, Multiple Myeloma Program, Hemophilia & Sickle Cell Disease Program, Burkitt’s & Lymphoma’s Program, Karposi Sarcoma Program, among others.
Prof. Chite has also developed a number of training curricula including the Medical Oncology Fellowship Curriculum for Kenya, Higher National Diploma for Registered Clinical Officers in Medical Oncology, the ASCO-AMPATH Oncology Multidisciplinary Cancer Management Course (MCMC), the Oncology Nursing Curriculum and Capacity at AMPATH/MTRH, development of an Exchange Program between Indiana Hemophilia and Thrombosis Center and AMPATH Hematology at MTRH, development of an Oncology Pharmacy Curriculum, among others.
In July 2017, Prof. Chite was recognized for an Endowed Professorship by the Indiana Hemophilia and Thrombosis Center. For the past 3 years, he has served in a 20-member committee at the American Society of Clinical Oncology (ASCO) International Affairs Committee and previously served as the ASCO IDEA Working group member and ASCO MCMC Working Group Committee Member in 2013 and 2014.
Prof. Chite holds certifications from the American Board of Internal Medicine for Internal Medicine, Hematology & Medical Oncology.